Sanara MedTech Inc Q2 2024 Earnings Revenue Surpasses Estimates at 20. ...

SMTI Stock  USD 33.81  0.31  0.93%   
Under 50% of Sanara Medtech's traders are presently thinking to get in. The analysis of overall sentiment of trading Sanara Medtech stock suggests that some investors are interested at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
  
Revenue 20.2 million, up by 28 percent year-over-year, surpassing estimates of 19.10 million.Net Loss 3.5 million for Q2 2024, compared to a net loss of 1.9 mil

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Sanara Medtech Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Sanara Medtech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Sanara Medtech Fundamental Analysis

We analyze Sanara Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanara Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanara Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Sanara Medtech is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Sanara Medtech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.

Peers

Sanara Medtech Related Equities

PDEXPro Dex   22.96   
0%
100.0%
MLSSMilestone Scientific   6.32   
0%
27.0%
POCIPrecision Optics,   6.04   
0%
26.0%
NVSTEnvista Holdings   3.10   
0%
13.0%
MHUAMeihua International   2.78   
0%
12.0%
KRMDRepro Med   2.56   
0%
11.0%
ANGOAngioDynamics   2.09   
0%
9.0%
INFUInfuSystems Holdings   1.34   
0%
5.0%
LMATLeMaitre Vascular   1.07   
0%
4.0%
DXRDaxor   0.39   
0%
1.0%
MMSIMerit Medical   0.14   
0%
1.0%
UTMDUtah Medical   0.75   
3.0%
0%
HAEHaemonetics   1.55   
6.0%
0%
ATRAptarGroup   1.66   
7.0%
0%

Complementary Tools for Sanara Stock analysis

When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.